This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
Molina Healthcare's New Deal to Boost Its Medicaid Business
by Zacks Equity Research
Molina Healthcare's (MOH) new agreement intends to efficiently serve its Medicaid members, which, in turn, will likely boost its market presence.
Consumer Confidence Sees Revival in May: Here's What it Means
by Zacks.com
It seems that consumers' confidence got restored in May as lockdowns were eased and businesses gradually reopened. Government stimulus helped companies weather the coronavirus crisis and improve their customer sentiments.
Are Investors Undervaluing CVS Health (CVS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna Adds Capabilities to Expand Its Virtual Care Service
by Zacks Equity Research
Cigna (CI) has added a private messaging application to better serve its members amid COVID-19 breakout.
The Zacks Analyst Blog Highlights: NVIDIA, Coca-Cola, PetroChina, CVS Health and Zoom Video Communications
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Coca-Cola, PetroChina, CVS Health and Zoom Video Communications
Q1 Scorecard and Research Reports for NVIDIA, Coca-Cola, PetroChina & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Coca-Cola (KO) and PetroChina (PTR).
Cigna (CI) Dispenses Digital Services to Fight Coronavirus
by Zacks.com
Cigna (CI) offers digital solutions to facilitate real-time support to its customers for tracking coronavirus symptoms.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - May 11, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Stock Market News for May 7, 2020
by Zacks Equity Research
Benchmarks closed mixed on Wednesday as data showed that private payroll had furloughed more than 20 million workers in April, highlighting the economic impact of the pandemic.
CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate
by Zacks Equity Research
Within CVS Health's (CVS) Retail/LTC, the coronavirus pandemic results in greater use of 90-day prescriptions and early refills of maintenance medications in the quarter.
CVS Health (CVS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 17.18% and 5.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Microsoft, CVS, Boeing, Facebook and Sherwin-Williams
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, CVS, Boeing, Facebook and Sherwin-Williams
What's in the Cards for CVS Health (CVS) in Q1 Earnings?
by Zacks Equity Research
We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.
Top Research Reports for Microsoft, CVS Health & Boeing
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), CVS Health (CVS) and Boeing (BA).
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.43, moving +0.3% from the previous trading session.
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - April 29, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $61.31, moving +1.59% from the previous trading session.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - April 23, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Rite Aid (RAD) Expands Coronavirus Testing Site to Virginia
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations, marked by the opening of its 25th site at Richmond, VA, to help curb the effects of the pandemic.
Rite Aid's (RAD) Q4 Loss Wider Than Expected, Sales Rise Y/Y
by Zacks Equity Research
Strong revenues at pharmacy services and retail pharmacy segments aided Rite Aid's (RAD) Q4 results. Further, management issued FY21 view, which reflects no COVID-19 impacts.
3 Investing Facts About Required Minimum Distributions You Need to Know - April 17, 2020
by Zacks Equity Research
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
Teladoc Q1 Preliminary Results Gain From Coronavirus-Led Demand
by Zacks Equity Research
The rising adoption of telehealth services prompted by the coronavirus breakdown boosts Teladoc Health's (TDOC) business operations.
Bed Bath & Beyond (BBBY) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Bed Bath & Beyond (BBBY) reports solid Q4 results, despite sluggishness during the holiday season and higher clearance activities. Management holds back FY20 view due to CVOID-19 impacts.